Michael A. Brodlieb

Michael A. Brodlieb’s practice focuses on complex civil and commercial litigation, white collar criminal and regulatory defense, securities litigation, and mergers and acquisitions litigation. Mr. Brodlieb litigates in federal and state courts at the trial and appellate levels, and advises clients across a broad range of industries, including private equity, banking, real estate, and media. He also maintains an active pro bono practice, representing clients in criminal, immigration, and employment matters.

Prior to joining Schlam Stone & Dolan LLP, Mr. Brodlieb practiced at Paul, Weiss, Rifkind, Wharton & Garrison LLP, where he represented clients in complex commercial disputes and in criminal and regulatory matters. Before joining Paul Weiss, he completed a federal judicial clerkship with the Hon. Raymond J. Dearie in the U.S. District Court for the Eastern District of New York. Mr. Brodlieb received his J.D., magna cum laude, from Brooklyn Law School where he served as Editor-in-Chief of the Brooklyn Law Review.

Representative Matters:

  • Defended multinational investment bank in the dismissal of a Section 10b-5 security fraud suit brought in the Southern District of New York by an investor who opted out of a multi-million dollar class action settlement.
  • Defended a hedge fund in the dismissal of multi-billion dollar lawsuit brought by beneficiaries of a state pension alleging breach of trust and fiduciary duties.
  • Represented high net worth individuals in investigations by the Department of Justice and SEC arising out of claims of insider trading.
  • Represented a hedge fund in regulatory proceedings arising out of claims of insider trading.
  • Secured dismissal of claims filed against a real estate investment trust and its board of directors for alleged proxy statement misrepresentations and omissions in connection with a $1.4 billion acquisition.
  • Represented a major real estate developer in a contract dispute with a U.S. multinational hospitality company.
  • Represented a major real estate developer in the defense of a putative class action.
  • Defended a major pharmaceutical company in a lawsuit concerning antitrust allegations.
  • Represented a global financial institution in an SEC investigation.
  • Defended a private equity firm in breach of contract dispute concerning a “material adverse change” clause in connection with a proposed $550 million acquisition.